Accurate confidence intervals for the ratio of specific occurrence/exposure rates in risk and survival analysisDONGSHENG TU; GROSS, A. J.Biometrical journal. 1995, Vol 37, Num 5, pp 611-626, issn 0323-3847Article

Phase II Stopping Rules That Employ Response Rates and Early ProgressionGOFFIN, John R; DONGSHENG TU.Journal of clinical oncology. 2008, Vol 26, Num 22, pp 3715-3720, issn 0732-183X, 6 p.Article

Nonparametric confidence intervals for the ratio of marginal hazard rates of paired survival timesHUAN JIN; NAIQING ZHAO; DONGSHENG TU et al.Biometrical journal. 2012, Vol 54, Num 2, pp 197-213, issn 0323-3847, 17 p.Article

Adjustment of treatment effect for covariates in clinical trials : Statistical and regulatory issuesDONGSHENG TU; SHALAY, K; PATER, J et al.Drug information journal. 2000, Vol 34, Num 2, pp 511-523, issn 0092-8615Article

A Bartlett type correction for Wald test in Cox regression modelXIAO LI; YAOHUA WU; DONGSHENG TU et al.Statistics & probability letters. 2008, Vol 78, Num 16, pp 2614-2622, issn 0167-7152, 9 p.Article

Confidence bands for hazard rates under random censorshipCHENG, Ming-Yen; HALL, Peter; DONGSHENG TU et al.Biometrika. 2006, Vol 93, Num 2, pp 357-366, issn 0006-3444, 10 p.Article

Phase II cancer clinical trials with a one-sample log-rank test and its corrections based on the Edgeworth expansionXIAOQUN SUN; PENG, Paul; DONGSHENG TU et al.Contemporary clinical trials. 2011, Vol 32, Num 1, pp 108-113, issn 1551-7144, 6 p.Article

Rao's score tests in survival analysis: Examples and bartlett type adjustmentsDONGSHENG TU.Communications in statistics. Theory and methods. 2001, Vol 30, Num 8-9, pp 1521-1532, issn 0361-0926Conference Paper

Testing the Homogeneity of Two Survival Functions Against a Mixture Alternative Based on Censored DataLITING ZHU; XIANMING TAN; DONGSHENG TU et al.Communications in statistics. Simulation and computation. 2010, Vol 39, Num 3-5, pp 767-776, issn 0361-0918, 10 p.Article

Objective responses in patients with malignant melanoma or renal cell cancer in early clinical studies do not predict regulatory approvalGOFFIN, John; BARAL, Stefan; DONGSHENG TU et al.Clinical cancer research. 2005, Vol 11, Num 16, pp 5928-5934, issn 1078-0432, 7 p.Article

Randomised controlled trials in oncology closed early for benefit: Trends in methodology, results, and interpretationBOOTH, Christopher M; OHORODNYK, Pavlo; LITING ZHU et al.European journal of cancer (1990). 2011, Vol 47, Num 6, pp 854-863, issn 0959-8049, 10 p.Article

Decision making in adjuvant trials in breast cancer : the NCIC CTG MA.17 trial as an examplePATER, Joseph; DONGSHENG TU; SHEPHERD, Lois et al.Breast cancer research and treatment. 2008, Vol 108, Num 2, pp 265-269, issn 0167-6806, 5 p.Article

Metal-coated long period gratings for detection of corrosionDONGSHENG TU; YANBIAO LIAO; MING ZHANG et al.Proceedings of SPIE, the International Society for Optical Engineering. 2005, pp 59980G.1-59980G.8, issn 0277-786X, isbn 0-8194-6022-2, 1VolConference Paper

Alternate Endpoints for Screening Phase II Studies : Phase II Trials: Designs for the futureDHANI, Neesha; DONGSHENG TU; SARGENT, DanielJ et al.Clinical cancer research (Print). 2009, Vol 15, Num 6, pp 1873-1882, issn 1078-0432, 10 p.Article

Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: A report from the National Cancer Institute of Canada Clinical trials groupCRUMP, Michael; DONGSHENG TU; SHEPHERD, Lois et al.Journal of clinical oncology. 2003, Vol 21, Num 16, pp 3066-3071, issn 0732-183X, 6 p.Article

Longer-Term Outcomes of Letrozole Versus Placebo After 5 Years of Tamoxifen in the NCIC CTG MA.17 Trial: Analyses Adjusting for Treatment CrossoverHUAN JIN; DONGSHENG TU; NAIQING ZHAO et al.Journal of clinical oncology. 2012, Vol 30, Num 7, pp 718-721, issn 0732-183X, 4 p.Article

Determining the relationship between toxicity and quality of life in an ovarian Cancer chemotherapy clinical trialBUTLER, Lorna; BACON, Monica; CAREY, Mark et al.Journal of clinical oncology. 2004, Vol 22, Num 12, pp 2461-2468, issn 0732-183X, 8 p.Article

A Randomized, Double-Blind, Controlled Trial of Perioperative Administration of Gabapentin, Meloxicam and Their Combination for Spontaneous and Movement-Evoked Pain After Ambulatory Laparoscopic CholecystectomyGILRON, Ian; ORR, Elizabeth; DONGSHENG TU et al.Anesthesia and analgesia. 2009, Vol 108, Num 2, pp 623-630, issn 0003-2999, 8 p.Article

A Phase 2 Study of Platinum and Gemcitabine in Patients With Advanced Salivary Gland Cancer: A Trial of the NCIC Clinical Trials GroupLAURIE, Scott A; SIU, Lillian L; WINQUIST, Eric et al.Cancer. 2010, Vol 116, Num 2, pp 362-368, issn 0008-543X, 7 p.Article

A phase i pharmacokinetic and pharmacodynamic study of OGX-011, a 2'-methoxyethyl antisense oligonucleotide to clusterin, in patients with localized prostate cancerCHI, Kim N; EISENHAUER, Elizabeth; FAZLI, Ladan et al.Journal of the National Cancer Institute. 2005, Vol 97, Num 17, pp 1287-1296, issn 0027-8874, 10 p.Article

Randomized trial comparing cyclophosphamide, epirubicin, and fluorouracil with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer : Update of national cancer institute of Canada clinical trials group trial MA5LEVINE, Mark N; PRITCHARD, Kathleen I; BRAMWELL, Vivien H. C et al.Journal of clinical oncology. 2005, Vol 23, Num 22, pp 5166-5170, issn 0732-183X, 5 p.Article

Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trialGILRON, Ian; BAILEY, Joan M; DONGSHENG TU et al.Lancet (British edition). 2009, Vol 374, Num 9697, pp 1252-1261, issn 0140-6736, 10 p.Article

Lipid concentrations in postmenopausal women on letrozole after 5 years of tamoxifen: an NCIC CTG MA.17 sub-studyWASAN, Kishor M; GOSS, Paul E; HAYDN PRITCHARD, P et al.Breast cancer research and treatment. 2012, Vol 136, Num 3, pp 769-776, issn 0167-6806, 8 p.Article

A placebo-controlled randomized clinical trial of perioperative administration of gabapentin, rofecoxib and their combination for spontaneous and movement-evoked pain after abdominal hysterectomyGILRON, Ian; ORR, Elizabeth; DONGSHENG TU et al.Pain (Amsterdam). 2005, Vol 113, Num 1-2, pp 191-200, issn 0304-3959, 10 p.Article

Quality of Life in ovarian Cancer patients: Comparison of paclitaxel plus cisplatin, with cyclophosphamide plus cisplatin in a randomized studyBEZJAK, Andrea; DONGSHENG TU; BACON, Monica et al.Journal of clinical oncology. 2004, Vol 22, Num 22, pp 4595-4603, issn 0732-183X, 9 p.Article